Global Next Generation Cancer Diagnostics Market Research Report 2024(Status and Outlook)

Global Next Generation Cancer Diagnostics Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Next Generation Cancer Diagnostics Market Size was estimated at USD 2243.19 million in 2023 and is projected to reach USD 6211.22 million by 2029, exhibiting a CAGR of 18.50% during the forecast period.

This report provides a deep insight into the global Next Generation Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Cancer Diagnostics market in any manner.

Global Next Generation Cancer Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Cepheid

Koninklijke Philips N.V

F. Hoffmann-La Roche Ltd

Qiagen

Novartis AG

Abbott

Thermo Fisher Scientific

Opko Health

Myriad Genetics

Agilent Technologies

GE Healthcare

PerkinElmer

Genomic Health

Illumina

Hologic

Almac Group

Janssen Global Services

Sysmex Corporation

Market Segmentation (by Type)

Next Generation Sequencing

qPCR & Multiplexing

DNA Microarrays

Others

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Next Generation Cancer Diagnostics Market

Overview of the regional outlook of the Next Generation Cancer Diagnostics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Next Generation Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Next Generation Cancer Diagnostics Segment by Type
1.2.2 Next Generation Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Next Generation Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Next Generation Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Next Generation Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Next Generation Cancer Diagnostics Market Competitive Landscape
3.1 Global Next Generation Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Next Generation Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Next Generation Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Next Generation Cancer Diagnostics Industry Chain Analysis
4.1 Next Generation Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Next Generation Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Next Generation Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Next Generation Cancer Diagnostics Price by Type (2019-2024)
7 Next Generation Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Next Generation Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Next Generation Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 Next Generation Cancer Diagnostics Market Segmentation by Region
8.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.1 Global Next Generation Cancer Diagnostics Sales by Region
8.1.2 Global Next Generation Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Cepheid
9.1.1 Cepheid Next Generation Cancer Diagnostics Basic Information
9.1.2 Cepheid Next Generation Cancer Diagnostics Product Overview
9.1.3 Cepheid Next Generation Cancer Diagnostics Product Market Performance
9.1.4 Cepheid Business Overview
9.1.5 Cepheid Next Generation Cancer Diagnostics SWOT Analysis
9.1.6 Cepheid Recent Developments
9.2 Koninklijke Philips N.V
9.2.1 Koninklijke Philips N.V Next Generation Cancer Diagnostics Basic Information
9.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Overview
9.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Market Performance
9.2.4 Koninklijke Philips N.V Business Overview
9.2.5 Koninklijke Philips N.V Next Generation Cancer Diagnostics SWOT Analysis
9.2.6 Koninklijke Philips N.V Recent Developments
9.3 F. Hoffmann-La Roche Ltd
9.3.1 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Basic Information
9.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Overview
9.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd Business Overview
9.3.6 F. Hoffmann-La Roche Ltd Recent Developments
9.4 Qiagen
9.4.1 Qiagen Next Generation Cancer Diagnostics Basic Information
9.4.2 Qiagen Next Generation Cancer Diagnostics Product Overview
9.4.3 Qiagen Next Generation Cancer Diagnostics Product Market Performance
9.4.4 Qiagen Business Overview
9.4.5 Qiagen Recent Developments
9.5 Novartis AG
9.5.1 Novartis AG Next Generation Cancer Diagnostics Basic Information
9.5.2 Novartis AG Next Generation Cancer Diagnostics Product Overview
9.5.3 Novartis AG Next Generation Cancer Diagnostics Product Market Performance
9.5.4 Novartis AG Business Overview
9.5.5 Novartis AG Recent Developments
9.6 Abbott
9.6.1 Abbott Next Generation Cancer Diagnostics Basic Information
9.6.2 Abbott Next Generation Cancer Diagnostics Product Overview
9.6.3 Abbott Next Generation Cancer Diagnostics Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Next Generation Cancer Diagnostics Basic Information
9.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Overview
9.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 Opko Health
9.8.1 Opko Health Next Generation Cancer Diagnostics Basic Information
9.8.2 Opko Health Next Generation Cancer Diagnostics Product Overview
9.8.3 Opko Health Next Generation Cancer Diagnostics Product Market Performance
9.8.4 Opko Health Business Overview
9.8.5 Opko Health Recent Developments
9.9 Myriad Genetics
9.9.1 Myriad Genetics Next Generation Cancer Diagnostics Basic Information
9.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Overview
9.9.3 Myriad Genetics Next Generation Cancer Diagnostics Product Market Performance
9.9.4 Myriad Genetics Business Overview
9.9.5 Myriad Genetics Recent Developments
9.10 Agilent Technologies
9.10.1 Agilent Technologies Next Generation Cancer Diagnostics Basic Information
9.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Overview
9.10.3 Agilent Technologies Next Generation Cancer Diagnostics Product Market Performance
9.10.4 Agilent Technologies Business Overview
9.10.5 Agilent Technologies Recent Developments
9.11 GE Healthcare
9.11.1 GE Healthcare Next Generation Cancer Diagnostics Basic Information
9.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Overview
9.11.3 GE Healthcare Next Generation Cancer Diagnostics Product Market Performance
9.11.4 GE Healthcare Business Overview
9.11.5 GE Healthcare Recent Developments
9.12 PerkinElmer
9.12.1 PerkinElmer Next Generation Cancer Diagnostics Basic Information
9.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Overview
9.12.3 PerkinElmer Next Generation Cancer Diagnostics Product Market Performance
9.12.4 PerkinElmer Business Overview
9.12.5 PerkinElmer Recent Developments
9.13 Genomic Health
9.13.1 Genomic Health Next Generation Cancer Diagnostics Basic Information
9.13.2 Genomic Health Next Generation Cancer Diagnostics Product Overview
9.13.3 Genomic Health Next Generation Cancer Diagnostics Product Market Performance
9.13.4 Genomic Health Business Overview
9.13.5 Genomic Health Recent Developments
9.14 Illumina
9.14.1 Illumina Next Generation Cancer Diagnostics Basic Information
9.14.2 Illumina Next Generation Cancer Diagnostics Product Overview
9.14.3 Illumina Next Generation Cancer Diagnostics Product Market Performance
9.14.4 Illumina Business Overview
9.14.5 Illumina Recent Developments
9.15 Hologic
9.15.1 Hologic Next Generation Cancer Diagnostics Basic Information
9.15.2 Hologic Next Generation Cancer Diagnostics Product Overview
9.15.3 Hologic Next Generation Cancer Diagnostics Product Market Performance
9.15.4 Hologic Business Overview
9.15.5 Hologic Recent Developments
9.16 Almac Group
9.16.1 Almac Group Next Generation Cancer Diagnostics Basic Information
9.16.2 Almac Group Next Generation Cancer Diagnostics Product Overview
9.16.3 Almac Group Next Generation Cancer Diagnostics Product Market Performance
9.16.4 Almac Group Business Overview
9.16.5 Almac Group Recent Developments
9.17 Janssen Global Services
9.17.1 Janssen Global Services Next Generation Cancer Diagnostics Basic Information
9.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Overview
9.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product Market Performance
9.17.4 Janssen Global Services Business Overview
9.17.5 Janssen Global Services Recent Developments
9.18 Sysmex Corporation
9.18.1 Sysmex Corporation Next Generation Cancer Diagnostics Basic Information
9.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Overview
9.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Product Market Performance
9.18.4 Sysmex Corporation Business Overview
9.18.5 Sysmex Corporation Recent Developments
10 Next Generation Cancer Diagnostics Market Forecast by Region
10.1 Global Next Generation Cancer Diagnostics Market Size Forecast
10.2 Global Next Generation Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Next Generation Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Next Generation Cancer Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Next Generation Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostics by Type (2025-2030)
11.1.2 Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Next Generation Cancer Diagnostics by Type (2025-2030)
11.2 Global Next Generation Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Next Generation Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Next Generation Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings